Accurate measurement of pyruvate is particularly important in the detection of mitochondrial enzyme disorders. We describe a simple highperformance liquid chromatography assay for pyruvate with derivatization and fluorescence detection. Between-run variation is below 4·5% and the method is linear between 1 and 1200Ilmol/L. The mean recovery is 10I%. After sample pretreatment, the calculated pyruvate concentration proved to be stable for 15 days when samples were kept at -20°C.
INTRODUCTION
Mitochondrial enzyme disorders occur with a range of serious clinical symptoms. I The detection of these disorders relies on accurate measurement of the lactate/pyruvate ratio." This ratio, which reflects the cellular NADH/NAD+ ratio, is diagnostically more specific than the measurement of lactate alone.v' Pyruvate is at the intersection of several metabolic pathways and has recently raised interest as a protector of cardiac performance.V Traditionally, pyruvate is measured by an enzymatic method. Despite the fact that the recovery of this method can be insufficient," such methods are still widely used. The major source of potential error is in the sample pretreatment procedure and can lead to widely varying pH values in the enzymatic reaction. ' We therefore decided to develop a highperformance liquid chromatography (HPLC)based method for routine measurement of pyruvate. Such methods have been published, but are characterized by insufficient recovery, tedious extraction procedures and the use of an internal standard that is no longer commercially available.v'" Correspondence: Dr Raymond W Wulkan. E-mail: r.wulkanei.zuiderziekenhuis.nl
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MATERIALS AND METHODS
Reagents and standards Acetonitrile (gradient grade), perchloric acid (70%, w/v) and sodium 2-oxobutanoate (sodium oc-ketobutyrate) were obtained from Merck (Darmstadt, Germany). Sodium pyruvate was purchased from Fluka (Buchs, Switzerland); 0phenylene diamine (OPD), sodium P-hydroxybutyrate, sodium p-hydroxypyruvate, sodium oxalate, sodium laevulinate, sodium e-ketoglutarate and sodium oc-ketoisocaproate were from Sigma-Aldrich (Poole, UK). All reagents were analytical grade. Pyruvate control material at two levels was obtained from Sigma-Aldrich.
Lactate was measured enzymatically with an Hitachi 911 instrument (Roche Diagnostics, Mannheim, Germany) using reagents from Sigma-Aldrich. Enzymatic measurement of pyruvate was done with a commercial kit from Sigma-Aldrich.
All standards were made using de-ionized water. Calibration standards were prepared from a stock solution of sodium pyruvate (2,4 mmol/L), As an internal standard solution we used 0·8 mmol/L sodium 2-oxobutanoate. Both the pyruvate stock solution and the internal standard solution kept at 4°C are stable for at least I month.
Sample pretreatment Venous blood samples from non-fasting, healthy volunteers were collected into Vacutainerf tubes without additive (Becton Dickinson, Plymouth, UK) and deproteinized immediately by adding 900 ilL of blood, while vigorously mixing, in a tube containing an ice-cold mixture of 100ilL internal standard solution and 2 mL of 70% perchloric acid. The tube was kept in melting ice for 15min and then centrifuged for 20 min at 3000 g. The frozen supernatant can be stored at -20°C for at least 15 days.
A 300-IlL aliquot from the supernatant was added to I mL of the derivatization reagent (l2mmoljL OPD in 3 mol/L hydrochloric acid). The mixture was then incubated for 90 min in a water bath at 60°C and subsequently cooled in melting ice.
Instrumentation and chromatographic conditions
A sample volume of 10jlL was injected on a CIS reversed-phase column (jlBondapak, 0·39 x 15cm, lO-jlm particle size, 125A; from Waters, Etten-Leur, The Netherlands). The column was eluted isocratically with 70% ammonium acetate (0·35 mol/L) and 30% acetonitrile at a flow-rate of I mLjmin by means of a Waters 510 HPLC pump system. The column eluent was monitored ftuorimetrically at an excitation wavelength of 336 nm by the emission of 420 nm using a Waters 470 scanning fluorescence detector. The run time was set to 10min. Data acquisition was done using the Waters Millennium-32 software package, enabling calibration of the assays by the internal standard ratio method using peak heights.
RESULTS
Linearity and detection limit
The five-point calibration curves were linear in the range 1-190 Ilmol/L pyruvate with correlation coefficients greater than 0·9999. The calibration curve was linear to at least 1200llmol/L, but for clinical purposes such a high upper limit is unnecessary. We therefore chose a smaller range of 1-190 jlmoljL. The detection limit, defined as five times the standard deviation of the noise, was I jlmoljL. This limit can easily be lowered by injecting a larger sample volume. Again, this seems unnecessary in view of the expected clinical values.
Imprecision
Within-run imprecision
Blood taken from a healthy volunteer was deproteinized in four separate tubes. Four aliquots of each supernatant were derivatized and analysed in the same run. The resulting mean level was 100j.tmol/L, with a standard deviation of 3·1 j.tmoljL and a coefficient of variation of 3·1%.
Calibration standards were derivatized ten times and analysed in the same run. At levels of 13j.tmoljL and 102jlmol/L, this resulted in coefficients of variation of 1·6% and 0·8%, respectively. Between-run imprecision Commercial controls at two levels were analysed on 9 days. Coefficients of variation at 60 }.'mol/L and 173 j.tmoljL were 2·4% and 3·7%. Blood from three volunteers was deproteinized once and measured after derivatization on 5 separate days. Coefficients of variation were 2·9%, 4·3% and 3·0% (at 62, 56 and 117}.'mol/L, respectively). From a calibration standard of 12j.tmol/L analysed on 7 days, a coefficient of variation of 6·7% was calculated.
Recovery and interference
The recovery was tested with the blood of three volunteers by adding pyruvate standards to the blood before deproteinization. The final concentration of pyruvate was 7(}-230llmoljL. The recovery was between 95·6% and 107·2% (21 measurements, 95% confidence interval).
We did not find any interfering compounds in the blood of healthy volunteers. The following substances were tested and were found not to interfere at physiological concentrations: p-hydroxybutyrate, p-hydroxypyruvate, oxalate, laevulinate, e-ketoglutarate and IXketoisocaproate.
Reference interval
The 95% reference interval was estimated from the data obtained from a group of 18 healthy, adult, non-fasting volunteers. The reference range was 31-11lllmoljL; one result of 138·1 ,umoljL was considered an outlier (more than three standard deviations from the mean).
Lactate/pyruvate ratios were calculated from measurements in the same group. The 95% reference interval was 9·3-13·9, one value of 7·2 being considered an outlier (pyruvate within the reference range).
Sample stability
Three blood samples were deproteinized and the supernatants were frozen in aliquots at -20°C and analysed after several periods of time.
The decreases in apparent pyruvate concentration at 15 days remained within twice the between-day standard deviation. However, at 25 days, losses exceeded 8%. From these data we conclude that supernatants can be stored for no longer than 15 days without substantial decrease in measured pyruvate concentration.
DISCUSSION
Traditionally, pyruvate is measured enzymatically. In enzymatic methods, the deproteinized sample needs to be neutralized before the enzymatic reaction is started. The instability of pyruvate at neutral conditions't-" can easily result in low recovery if neutralized samples are stored. The pH values obtained after addition of deproteinized supernatants to butTer can vary widely and thus produce pyruvate concentrations varying by a factor of two to three.' Using a commercially available reagent kit, we likewise observed large inter-individual variations in pH after the neutralization step. Furthermore, with some samples a precipitate developed, necessitating an extra centrifugation step.
We therefore decided to develop a more precise and robust method for pyruvate based on HPLC with fluorescence detection. This work is based on the early method of Liao et al. for pyruvate in urine samples."
Derivatization and choice of internal standard
The Hinsberg reaction producing a quinoxalinone derivative from pyruvate and a-phenylenediamine has been known for some time and has been studied in detail.P:" Stijntjes et al., working with rat renal cytosolic fractions, found that the derivatization reaction of pyruvate went to 95% completion in 60 min." We tested pyruvate and 2oxobutanoate and found that the conversion of both compounds reached a plateau at 8(}-90min (results not shown).
2-0xobutanoate was selected as an internal standard to reflect as closely as possible the behaviour of pyruvate. 2-0xobutanoate differs from pyruvate by one methylene group. We tested several compounds before choosing 2oxobutanoate. Another internal standard (sodium ketovalerate) that has recently been proposed!" is no longer commercially available.
Although 2-oxobutanoate is satisfactory as an internal standard, there has been one report describing a rare inborn error of metabolism that leads to appreciable plasma concentrations of 2-hydroxybutanoate. 16 In theory, this compound, if oxidized to 2-oxobutanoate, would add to the internal standard peak and consequently would lead to underestimation of pyruvate. To avoid this problem, we recommend that the peak height of the internal standard is Ann Clin Biochem 2001: 38 monitored closely. If inappropriately elevated, a second sample from the same drawn blood sample should be analysed without internal standard. The in vivo contribution of 2-oxobutanoate can then be subtracted, thus permitting a correct calculation. In patients with lactic acidosis or ketoacidosis, low concentrations « 50 ).ImoljL) of 2-hydroxybutanoate have been found. I? Rosalki and Wilkinson observed that 2-oxobutanoate, when added to serum, underwent enzymatic reduction." We could not find any reports describing the occurrence of 2-oxobutanoate in blood. We analysed a number of samples from healthy volunteers without addition of internal standard and we never observed a relevant peak at the position of the internal standard. Likewise, Landaas and Pettersen, using gas chromatography and mass spectrometry did not find any 2-oxobutanoate in blood from patients with various clinical disorders. 17 For sampling, tubes with fluoride/oxalate (Becton Dickinson) may be used without affecting the results. This has the advantage that lactate can be measured in a sample from the same draw. For paediatric purposes, the required blood volume can easily be reduced to 100).lL.
We do not advocate the measurement of pyruvate in serum, reported by some authors.v'? because without immediate deproteinization losses of pyruvate reach 15-50% within 30min. 19 In other methods, the internal standard is added late in the sample pretreatment procedure (e.g. to thawed serum) or after derivatization.v!? We chose to add it immediately after the blood sampling, thus reflecting more accurately the fate of pyruvate itself. Figure 1 is a representative chromatogram. One early peak that appears in most chromatograms remains unidentified.
The preliminary reference range for the lactate/ pyruvate ratio of 9·3-13'9 (17 non-fasting adults) is comparable to that of Poggi-Travert et al. 2 
CONCLUSION
An accurate and precise method for the measurement of pyruvate in blood has been presented. In contrast to other methods, there is no need for neutralization? or extraction."!" or for the use of a solvent gradientv'" or two internal standards." The imprecision of this method is about half the required analytical goal of 7'6% as derived from the biological variation of pyruvate." We hope that this method will contribute to a reliable detection of mitochondrial enzyme disorders.
II Lin S-S, Miyawaki 0, Nakamura K. Continuous production of i.-alanine with NADH regeneration by a nanofiltration membrane reactor. Biosci
